1
|
Persson A, Seton R. Modeling and Evaluation of a Rate-Based Transcutaneous Blood Gas Monitor. IEEE Trans Biomed Eng 2023; 70:3178-3186. [PMID: 37224374 DOI: 10.1109/tbme.2023.3279514] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
OBJECTIVE Current methods for transcutaneous blood gas monitoring (TBM) - a common health monitoring method in neonatal care - comes with a suite of challenges like limited attachment opportunities, and risks of infections from burning and tearing of the skin, which limits its use. This study presents a novel system and method for rate-based transcutaneous CO2 measurements with a soft, unheated skin-interface that can address many of these problems. Additionally, a theoretical model for the gas transport from the blood to the system's sensor is derived. METHODS By simulating CO2 advection and diffusion through the cutaneous microvasculature and epidermis to the system's skin interface, the effect of a wide range of physiological properties on the measurement has been modeled. Following these simulations, a theoretical model for the relationship between the measured CO2 concentration and that in the blood was derived and compared to empirical data. RESULTS Applying the model on measured blood gas levels, even when the theory was based solely on the simulations, produced blood CO2 concentrations within ∼35% of empirical measurements from a state-of-the-art device. Further calibration of the framework, also using the empirical data, yielded an output with a Pearson correlation of 0.84 between the two methods. CONCLUSION Compared to the state-of-the-art device the proposed system measured the partial CO2 pressure in the blood with an average deviation of 0.04 kPa and 1.97σ of ±1.1 kPa. However, the model indicated that this performance could be hampered by different skin properties. SIGNIFICANCE Given its soft and gentle skin interface and lack of heating, the proposed system could significantly decrease health risks like, burns, tears, and pain, currently associated with TBM on premature neonates.
Collapse
|
2
|
Borenstein-Levin L, Avishay N, Soffer O, Arnon S, Riskin A, Dinur G, Lavie-Nevo K, Gover A, Kugelman A, Hochwald O. Transcutaneous CO 2 Monitoring in Extremely Low Birth Weight Premature Infants. J Clin Med 2023; 12:5757. [PMID: 37685823 PMCID: PMC10488371 DOI: 10.3390/jcm12175757] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2023] [Revised: 08/29/2023] [Accepted: 08/30/2023] [Indexed: 09/10/2023] Open
Abstract
Extremely low birth weight (ELBW) premature infants are particularly susceptible to hypocarbia and hypercarbia, which are associated with brain and lung morbidities. Transcutaneous CO2 (TcCO2) monitoring allows for continuous non-invasive CO2 monitoring during invasive and non-invasive ventilation and is becoming more popular in the NICU. We aimed to evaluate the correlation and agreement between CO2 levels measured by a TcCO2 monitor and blood gas CO2 (bgCO2) among ELBW infants. This was a prospective observational multicenter study. All infants < 1000 g admitted to the participating NICUs during the study period were monitored by a TcCO2 monitor, if available. For each bgCO2 measured, a simultaneous TcCO2 measurement was documented. In total, 1828 pairs of TcCO2-bgCO2 values of 94 infants were collected, with a median (IQR) gestational age of 26.4 (26.0, 28.3) weeks and birth weight of 800 (702, 900) g. A moderate correlation (Pearson: r = 0.64) and good agreement (bias (95% limits of agreement)):(2.9 [-11.8, 17.6] mmHg) were found between the TcCO2 and bgCO2 values in the 25-70 mmHg TcCO2 range. The correlation between the TcCO2 and bgCO2 trends was moderate. CO2 measurements by TcCO2 are in good agreement (bias < 5 mmHg) with bgCO2 among premature infants < 1000 g during the first week of life, regardless of day of life, ventilation mode (invasive/non-invasive), and sampling method (arterial/capillary/venous). However, wide limits of agreement and moderate correlation dictate the use of TcCO2 as a complementary tool to blood gas sampling, to assess CO2 levels and trends in individual patients.
Collapse
Affiliation(s)
- Liron Borenstein-Levin
- Department of Neonatology, Rambam Health Care Campus, Haifa 3109601, Israel; (O.S.); (G.D.); (A.K.); (O.H.)
- Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3200003, Israel; (N.A.); (A.R.); (K.L.-N.); (A.G.)
| | - Noa Avishay
- Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3200003, Israel; (N.A.); (A.R.); (K.L.-N.); (A.G.)
| | - Orit Soffer
- Department of Neonatology, Rambam Health Care Campus, Haifa 3109601, Israel; (O.S.); (G.D.); (A.K.); (O.H.)
| | - Shmuel Arnon
- Department of Neonatology, Meir Medical Center, Kfar-Saba 4428164b, Israel;
- Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel
| | - Arieh Riskin
- Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3200003, Israel; (N.A.); (A.R.); (K.L.-N.); (A.G.)
- Department of Neonatology, Bnai Zion Medical Center, Haifa 32000, Israel
| | - Gil Dinur
- Department of Neonatology, Rambam Health Care Campus, Haifa 3109601, Israel; (O.S.); (G.D.); (A.K.); (O.H.)
- Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3200003, Israel; (N.A.); (A.R.); (K.L.-N.); (A.G.)
| | - Karen Lavie-Nevo
- Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3200003, Israel; (N.A.); (A.R.); (K.L.-N.); (A.G.)
- Department of Neonatology, Carmel Medical Center, Haifa 3436212, Israel
| | - Ayala Gover
- Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3200003, Israel; (N.A.); (A.R.); (K.L.-N.); (A.G.)
- Department of Neonatology, Carmel Medical Center, Haifa 3436212, Israel
| | - Amir Kugelman
- Department of Neonatology, Rambam Health Care Campus, Haifa 3109601, Israel; (O.S.); (G.D.); (A.K.); (O.H.)
- Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3200003, Israel; (N.A.); (A.R.); (K.L.-N.); (A.G.)
| | - Ori Hochwald
- Department of Neonatology, Rambam Health Care Campus, Haifa 3109601, Israel; (O.S.); (G.D.); (A.K.); (O.H.)
- Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3200003, Israel; (N.A.); (A.R.); (K.L.-N.); (A.G.)
| |
Collapse
|
3
|
Tufan TB, Sen D, Guler U. An Infra-Red-Based Prototype for a Miniaturized Transcutaneous Carbon Dioxide Monitor. ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY. IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY. ANNUAL INTERNATIONAL CONFERENCE 2021; 2021:7132-7135. [PMID: 34892745 DOI: 10.1109/embc46164.2021.9630469] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
New types of miniaturized biomedical devices transform contemporary diagnostic and therapeutic techniques in medicine. This evolution has demonstrated exceptional promise in providing infrastructures for enabling precision health by creating diverse sensing modalities. To this end, this paper presents a prototype for transcutaneous carbon dioxide monitoring to diversify the measurable critical parameters for human health. Transcutaneous carbon dioxide monitoring is a noninvasive, surrogate method of assessing the partial pressure of carbon dioxide in the blood. The partial pressure of carbon dioxide is a vital index that can help understand momentarily changing ventilation trends. Therefore, it needs to be reported continuously to monitor the ventilatory status of critically ill patients. The proposed prototype employs an infrared LED as the excitation source. The infrared emission, which decreases in response to an increasing carbon dioxide concentration, is applied to a thermopile sensor that can detect the infrared intensity variations precisely. We have measured the changes in the partial pressure of carbon dioxide in the range of 0-120 mmHg, which covers humans' typical values, 35-45 mmHg. The prototype occupies an area of 25 cm2 (50 mm × 50 mm) and consumes 85 mW power.
Collapse
|
4
|
Williams E, Dassios T, Greenough A. Carbon dioxide monitoring in the newborn infant. Pediatr Pulmonol 2021; 56:3148-3156. [PMID: 34365738 DOI: 10.1002/ppul.25605] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/23/2021] [Revised: 07/28/2021] [Accepted: 07/29/2021] [Indexed: 11/06/2022]
Abstract
Carbon dioxide (CO2 ) monitoring is vital during mechanical ventilation of newborn infants, as morbidity increases when CO2 levels are inappropriate. Our aim was to review the uses and limitations of such noninvasive monitoring methods. Colorimetry is primarily utilized during resuscitation to determine whether successful intubation has occurred. False negative and positive results can however lead to delays in detecting tracheal versus esophageal intubation. Transcutaneous carbon dioxide sensors have limited use during resuscitation, but can be utilized to provide continuous trend data during on-going ventilation. End-tidal capnography can provide clinicians with quantitative end-tidal CO2 (EtCO2 ) values and a continuous real-time capnogram waveform trace. These devices are becoming more widely accepted for use in the neonatal population as the new devices are lightweight with minimal additional dead space. Nevertheless, they have been reported to have variable accuracy when compared to arterial CO2 measurements, however, divergence of results may be related to disease severity rather than technological limitations. During resuscitation EtCO2 can be detected by capnography more rapidly than by colorimetry. Furthermore, capnography can be currently utilized in neonatal research settings to determine the physiological dead space and ventilation inhomogeneity, and thus has potential to be beneficial to clinical care. In conclusion, novel modes of noninvasive carbon dioxide monitoring can be safely and reliably utilized in newborn infants during mechanical ventilation. Future randomized trials should aim to address which device provides the most optimal form of monitoring in different clinical contexts.
Collapse
Affiliation(s)
- Emma Williams
- Department of Woman and Children's Health, School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK
| | - Theodore Dassios
- Department of Woman and Children's Health, School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.,Neonatal Intensive Care Centre, King's College Hospital NHS Foundation Trust, London, UK
| | - Anne Greenough
- Department of Woman and Children's Health, School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.,Asthma UK Centre for Allergic Mechanisms in Asthma, King's College London, London, UK.,National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK
| |
Collapse
|
5
|
van Weteringen W, van Essen T, Gangaram-Panday NH, Goos TG, de Jonge RCJ, Reiss IKM. Validation of a New Transcutaneous tcPO2/tcPCO2 Sensor with an Optical Oxygen Measurement in Preterm Neonates. Neonatology 2020; 117:628-636. [PMID: 32998134 DOI: 10.1159/000510659] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/02/2020] [Accepted: 07/20/2020] [Indexed: 11/19/2022]
Abstract
INTRODUCTION Traditional transcutaneous oxygen (tcPO2) measurements are affected by measurement drift, limiting accuracy and usability. The new potentially drift-free oxygen fluorescence quenching technique has been combined in a single sensor with conventional transcutaneous carbon dioxide (tcPCO2) monitoring. This study aimed to validate optical tcPO2 and conventional tcPCO2 against arterial blood gas samples in preterm neonates and determine measurement drift. METHODS In this prospective observational study, during regular care, transcutaneous measurements were paired to arterial blood gases from preterm neonates aged 24-31 weeks of gestational age (GA) with an arterial catheter. Samples were included based on stability criteria and stratified for sepsis status. Agreement was assessed using the Bland-Altman analysis. Measurement drift per hour was calculated. RESULTS Sixty-eight premature neonates were included {median (interquartile range [IQR]) GA of 26 4/7 [25 3/7-27 5/7] weeks}, resulting in 216 stable paired samples. Agreement of stable samples in neonates without sepsis (n = 38) and with suspected sepsis (n = 112) was acceptable for tcPO2 and good for tcPCO2. However, in stable samples of neonates with sepsis (n = 66), tcPO2 agreement (bias and 95% limits of agreement) was -32.6 (-97.0 to 31.8) mm Hg and tcPCO2 agreement was 4.2 (-10.5 to 18.9) mm Hg. The median (IQR) absolute drift values were 0.058 (0.0231-0.1013) mm Hg/h for tcPO2 and 0.30 (0.11-0.64) mm Hg/h for tcPCO2. CONCLUSION The accuracy of optical tcPO2 in premature neonates was acceptable without sepsis, while electrochemically measured tcPCO2 remained accurate under all circumstances. Measurement drift was negligible for tcPO2 and highly acceptable for tcPCO2.
Collapse
Affiliation(s)
- Willem van Weteringen
- Department of Pediatric Surgery, Erasmus MC - Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands, .,Department of Pediatrics, Division of Neonatology, Erasmus MC - Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands,
| | - Tanja van Essen
- Department of Pediatrics, Division of Neonatology, Erasmus MC - Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands
| | - Norani H Gangaram-Panday
- Department of Pediatrics, Division of Neonatology, Erasmus MC - Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands
| | - Tom G Goos
- Department of Pediatrics, Division of Neonatology, Erasmus MC - Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands.,Department of Biomechanical Engineering, Faculty of Mechanical Engineering, Delft University of Technology, Delft, The Netherlands
| | - Rogier C J de Jonge
- Pediatric Intensive Care Unit, Departments of Pediatrics and Pediatric Surgery, Erasmus MC - Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands
| | - Irwin K M Reiss
- Department of Pediatrics, Division of Neonatology, Erasmus MC - Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands
| |
Collapse
|